Schedule

    Track 1 Track 2

March 28, 2017

7:00 AM
Registration
7:00 AM - 4:30 PM
7:00 AM
Breakfast
 7:00 AM - 8:00 AM
8:00 AM
Pioneering Precision: Industry's Move Toward a Targeted Era

Welcome Remarks

Christopher J. Wells, MPA, Director, Communications, Personalized Medicine Coalition

8:00 AM - 8:25 AM
8:30 AM
Opening Keynote

SETTING THE STAGE: An inside look at recent trends and outcomes in personalized medicine investments and joint ventures, plus a forecast for future innovation and funding in the space

Nick Naclerio, PhD, Founder and Managing Partner, Illumina Ventures

8:30 AM - 9:00 AM
9:05 AM
Financing Strategies for Precision Medicine Ventures

Plenary Session

John Doulis, MD, Chief Informatics and Information Officer, MedCare Investment Funds

Manuel J. Glynias, President and Chief Executive Officer, GenomOncology

Samuel D. Riccitelli, Former President and Chief Executive Officer, Signal Genetics

MODERATOR: Jeffrey S. Karan, Managing Partner, WaveEdge Capital

9:05 AM - 9:55 AM
9:55 AM
Networking Break
9:55 AM - 10:25 AM
10:25 AM
Moving Targets: Strategies to Prepare for Reimbursement Trends and Changes in Payment Policies

Plenary Session

Anita J. Chawla, PhD, Managing Principal, Analysis Group

Mark McCoy, MBA, Senior Director, Reimbursement, Guardant Health, Inc.

Amber Trivedi, MS, CGC, Senior Vice President, Market Development and Innovation, InformedDNA

MODERATOR: Judith A. Waltz, Partner, Foley & Lardner LLP

10:25 AM - 11:15 AM
11:20 AM
Creating a Coordinated Path Forward: Biomarkers in Drug Discovery and Clinical Practice

Breakout Session - Track 1

Mark Frasier, PhD, Senior Vice President, Research Programs, The Michael J. Fox Foundation for Parkinson's Research

Pamela Garzone, PhD, Vice President, Early Oncology Development and Clinical Research, Pfizer

Sally A. Howard, JD, Head of Regulatory Affairs and Policy, Human Longevity, Inc.

David Litwack, PhD, Personalized Medicine Staff, Center for Devices and Radiological Health, FDA

MODERATOR: Christine Meda, Chief Business Officer, IncellDx

11:20 AM - 12:10 PM
Launching a Precision Medicine Program: Real-World Solutions to Practical Challenges

Breakout Session - Track 2

Anna B. Berry, MD, Scientific Director of Personalized Medicine, Swedish Cancer Institute & Medical Director of Molecular Diagnostics, CellNetix Pathology and Laboratories

Timothy L. Cannon, MD, Medical Oncologist and Clinical Director, Molecular Tumor Board and Personalized Medicine Initiative, Inova Schar Cancer Institute

Brad Perkins, MD, Chief Medical Officer, Human Longevity, Inc.

MODERATOR: Jennifer Levin Carter, MD, MPH, Chief Medical Officer and Founder, N-of-One

11:20 AM - 12:10 PM
12:10 PM
Luncheon
12:10 PM - 1:10 PM
1:10 PM
Pushing the Envelope: Innovative Next-Generation Sequencing Technologies and Applications

Breakout Session - Track 1

Amanda Cashin, PhD, Co-Founder and Head, Illumina Accelerator

Justin Kao, Co-Founder and Senior Vice President of Business Development and Partnerships, Helix

Pieter van Rooyen, PhD, President and Chief Executive Officer, Edico Genome

MODERATOR: Ashley Van Zeeland, PhD, MBA, Chief Technology Officer, Human Longevity, Inc.

1:10 PM - 2:00 PM
Clinical Adoption of Personalized Medicine: Challenges and Solutions

Breakout Session - Track 2

Nicholas C. Dracopoli, PhD, Vice President and Head of Oncology Biomarkers, Janssen Research & Development, LLC

Gregory Frank, PhD, Former Director, Business Development, 23andMe

Maurie Markman, MD, President of Medicine and Science, Cancer Treatment Centers of America

MODERATOR: Kalidip “KC” Choudhury, PhD, Vice President, Business Development, XBiotech

1:10 PM - 2:00 PM
2:05 PM
Expanding the Possibilities of Personalized Medicine Through Collaborative Data Collection, Sharing, and Analysis

Plenary Session

Nicholas Donoghoe, MD, Partner, McKinsey & Company

Leeland Ekstrom, PhD, Managing Director, BioVU Partnerships, Vanderbilt University Medical Center & Founder, Nashville Biosciences

Gary (Yuan) Gao, PhD, Co-Founder, President and Chief Executive Officer, Med Data Quest, Inc. & Co-Founder and Chairman of the Board, Singlera Genomics

Tara Maddala, PhD, Head of Biostatistics and Data Management, GRAIL, Inc.

MODERATOR: Beni Surpin, Partner, Foley & Lardner LLP

2:05 PM - 2:55 PM
3:00 PM
Closing Keynote

BEHIND THE SCENES: An exclusive look at the formation of dRx Capital AG and the strategy behind the Novartis and Qualcomm digital/pharma collaboration

Lucian Iancovici, MD, General Partner, dRx Capital AG & Senior Investment Manager, Qualcomm Life Fund, Qualcomm Ventures

Aaron Nelson, MD, PhD, General Partner, dRx Capital AG

3:00 PM - 3:30 PM
3:30 PM
Networking Break
3:30 PM - 4:00 PM
4:00 PM
First Pitch: Personalized Medicine

NEW FOR 2017! Seed to Series A Startup, Investor, and Researcher Demo Day

COMPANY PRESENTERS:

MODERATOR: Matt Gardner, Founder and Chief Executive Officer, California Technology Council

4:00 PM - 6:00 PM
6:00 PM
Closing Reception
6:00 PM - 7:00 PM
 

Download copies of past BPM Summit program books:

2013 2014 2015